InvestorsHub Logo
Followers 21
Posts 2520
Boards Moderated 0
Alias Born 12/07/2013

Re: None

Friday, 06/11/2021 10:27:17 AM

Friday, June 11, 2021 10:27:17 AM

Post# of 424161
Amarin Corporation (AMRN) Symphony Data Shows Vacepta in Uptrend - Cantor Fitzgerald
June 11, 2021 8:10 AM EDT
Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating and $10.00 price target on Amarin Corporation (NASDAQ: AMRN) noting that ...


https://www.streetinsider.com/Analyst+Comments/Amarin+Corporation+%28AMRN%29+Symphony+Data+Shows+Vacepta+in+Uptrend+-+Cantor+Fitzgerald/18549422.html

In JUne of 2020 she said $35

All in all, Chen rates AMRN an Overweight (i.e. Buy) along with a $35 price target.



https://www.yahoo.com/news/amarin-soar-420-over-next-185800359.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News